Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Wellgistics Health, Inc. (WGRX : NSDQ)

• Company Description    Wellgistics LLC is a pharmaceutical wholesaler distributor, bridging the gap between small to mid-size pharmaceutical manufacturers and independent retail pharmacies. Wellgistics LLC, formerly known as Danam Health Inc., is based in Tampa, FL. Number of Employees: 31

• Price / Volume Information    Yesterday's Closing Price: $0.58 Daily Weekly Monthly 20 Day Moving Average: 804,336 shares Shares Outstanding: 89.73 (millions) Market Capitalization: $52.04 (millions) Beta: 52 Week High: $5.69 52 Week Low: $0.34 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week -0.87% -2.97% 12 Week -47.75% -48.69% Year To Date % %

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 3000 BAYPORT DRIVE SUITE 950 - TAMPA,FL 33607 USA ph: 844-203-6092 fax: - ir@wellgisticshealth.com http://www.wellgisticshealth.com

• General Corporate Information    Officers Brian Norton - Chief Executive Officer Suren Ajjarapu - Chairman Prashant Patel - Vice Chairman Vishnu Balu - Chief Financial Officer Donald W. Anderson - Director Peer Information - (-) - (-) - (-) - (-) - (-) - (-) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED-DRUGS Sector: Medical CUSIP: 949503106 SIC: 5122 Fiscal Year Fiscal Year End: December Last Reported Quarter: 09/01/25 Next Expected EPS Date: 03/24/26 Share - Related Items Shares Outstanding: 89.73 Most Recent Split Date: (:1) Beta: Market Capitalization: $52.04 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $ Payout Ratio: Number of Estimates in the Fiscal Year Consensus: Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 03/24/26

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: 7.67 Price/Cash Flow: - Price / Sales: 1.53 EPS Growth vs. Year Ago Period: -% vs. Previous Quarter: -300.00% Sales Growth vs. Year Ago Period: -46.90% vs. Previous Quarter: -61.33% ROE 09/30/25 - -1,617.25 06/30/25 - -1,495.36 03/31/25 - -1,398.52 ROA 09/30/25 - -137.41 06/30/25 - -106.83 03/31/25 - -135.89 Current Ratio 09/30/25 - 0.39 06/30/25 - 0.32 03/31/25 - 0.36 Quick Ratio 09/30/25 - 0.16 06/30/25 - 0.11 03/31/25 - 0.15 Operating Margin 09/30/25 - -224.19 06/30/25 - -123.31 03/31/25 - -135.22 Net Margin 09/30/25 - -228.17 06/30/25 - -123.31 03/31/25 - -135.22 Pre-Tax Margin 09/30/25 - -228.16 06/30/25 - -123.31 03/31/25 - -135.22 Book Value 09/30/25 - 0.08 06/30/25 - 0.01 03/31/25 - 0.09 Inventory Turnover 09/30/25 - 3.51 06/30/25 - 4.78 03/31/25 - 5.51 Debt-to-Equity 09/30/25 - 1.86 06/30/25 - 11.16 03/31/25 - 1.43 Debt-to-Capital 09/30/25 - 65.02 06/30/25 - 91.78 03/31/25 - 58.83

Powered by Zacks Investment Research ©